Pradaxa Patients Face Bleeding Risks Despite Antidote
Pradaxa Patients Face Bleeding Risks Despite Antidote. The bleeding risk for people taking the blood-thinning drug Pradaxa is well documented, and the risk persists despite a recently developed bleeding antidote. Many patients allege that the drug maker was reckless in introducing Pradaxa to the market with a bleeding … [Read more...] about Pradaxa Patients Face Bleeding Risks Despite Antidote
Warfarin May Lead to Brain Hemorrhages
Blood-Thinning Drug Warfarin May Cause Brain Hemorrhage. A new study published in today’s edition of the journal Neurology has raised serious safety concerns about the blood-thinning drug warfarin. According to researchers at the University of Cincinnati College of Medicine, the drug may lead to an increased risk of a brain … [Read more...] about Warfarin May Lead to Brain Hemorrhages
AstraZeneca Withdraws Exanta from European Market
AstraZeneca Withdraw Exanta From The Market. The Associated Press has reported that pharmaceutical giant, AstraZeneca PLC, has announced it is withdrawing its controversial blood-thinning drug Exanta from the market and ending its further development due to “links to liver injury.” The drug is marketed only in Europe … [Read more...] about AstraZeneca Withdraws Exanta from European Market
